GTHA Jumps Up on Hypertension Contract News
Shares of GeneThera Inc. (OTCBB: GTHA) jumped up 45 percent, in early trading today, gaining $0.0145 to $0.0455 per share on volume of 854,948. The company announced that it has received a contract from the Intramural Research Program, National Institute on Aging, and National Institutes of Health (NIH) to genetically engineer monoclonal antibodies and make them “clinically usable.” The antibodies are expected to be used for treatment of hypertension. “We are very delighted at the opportunity to work with the NIH; the largest research organization in the world. I believe this is a great opportunity for GeneThera Inc,” stated Dr.…